A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins

Goldstein, Joseph L., Brown, Michael S.·2015·Cell

Cited by (1,000)

Items 101–200 of 1,000

  1. Mechanisms of statin-associated skeletal muscle-associated symptoms
    Jamal Bouitbir, Gerda M. Sanvee, Miljenko Valentin Panajatovic, François Singh, Stephan Krähenbühl · 2019 · Pharmacological Research
  2. Understanding the molecular mechanisms of statin pleiotropic effects
    Charles Amir German, James K. Liao · 2023 · Archives of Toxicology
  3. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk
    Huang, Yu-Wen Alvin, Zhou, Bo, Nabet, Amber M., Wernig, Marius, Südhof, Thomas C. · 2019 · The Journal of Neuroscience
  4. Vascular inflammation and low‐density lipoproteins: is cholesterol the link? A lesson from the clinical trials
    Alberico Luigi Catapano, Angela Pirillo, Giuseppe Danilo Norata · 2017 · British Journal of Pharmacology
  5. Lysosomal control of senescence and inflammation through cholesterol partitioning
    Kyeonghwan Roh, Jeonghwan Noh, Yeonju Kim, Yeji Jang, Jae‐Jin Kim, Haebeen Choi, Yeonghyeon Lee, Moongi Ji, Donghyun Kang, Mi-Sung Kim et al. · 2023 · Nature Metabolism
  6. Liver X receptors at the intersection of lipid metabolism and atherogenesis
    Stephen D. Lee, Peter Tontonoz · 2015 · Atherosclerosis
  7. Targeting IL-1β in the Treatment of Atherosclerosis
    Wuqian Mai, Yuhua Liao · 2020 · Frontiers in Immunology
  8. Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth
    Chunming Cheng, Feng Geng, Zoe Li, Yaogang Zhong, Huabao Wang, Xiang Cheng, Yue Zhao, Xiaokui Molly Mo, Craig Horbinski, Wenrui Duan et al. · 2022 · Nature Metabolism
  9. Protective alleles and modifier variants in human health and disease
    Andrew Robert Harper, Shalini Nayee, Eric J. Topol · 2015 · Nature Reviews Genetics
  10. Molecular basis of accessible plasma membrane cholesterol recognition by the GRAM domain of GRAMD1b
    Bilge Ercan, Tomoki Naito, Dylan Hong Zheng Koh, Dennis Dharmawan, Yasunori Saheki · 2021 · The EMBO Journal
  11. Butyrate generated by gut microbiota and its therapeutic role in metabolic syndrome
    Stephanie Claire Bridgeman, Wendy Northrop, Phillip E. Melton, Gaewyn Ellison, Philip Newsholme, Cyril D S Mamotte · 2020 · Pharmacological Research
  12. Lipid metabolism in pancreatic cancer: emerging roles and potential targets
    Xinpeng Yin, Ruiyuan Xu, Jianlu Song, Rexiati Ruze, Yuan Chen, Chengcheng Wang, Qiang Xu · 2022 · 癌症:英文版
  13. The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better
    Omar Mhaimeed, Zain Ali Burney, Stacey L. Schott, Payal Kohli, Francoise Adeline Marvel, Seth Shay Martin · 2024 · American Journal of Preventive Cardiology
  14. Oxidative theory of atherosclerosis and antioxidants
    Robert Salvayre, Anne Nègre‐Salvayre, Caroline Camaré · 2015 · Biochimie
  15. Regulation of PCSK9 Expression and Function: Mechanisms and Therapeutic Implications
    Xia, Xiao-dan, Peng, Zhong-sheng, Gu, Hong-mei, Wang, Maggie, Wang, Gui-qing, Zhang, Da-wei · 2021 · Frontiers in Cardiovascular Medicine
  16. Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality
    Mara Sophie Vell, Rohit Seth Loomba, Arunkumar Krishnan, Kirk J. Wangensteen, Jonel Trebicka, Kate Townsend Creasy, Christian Trautwein, Eleonora Scorletti, Katharina Sophie Seeling, Leonida Hehl et al. · 2023 · JAMA Network Open
  17. Lysosomes: Signaling Hubs for Metabolic Sensing and Longevity
    Marzia Savini, Qian Zhao, Meng Carla Wang · 2019 · Trends in Cell Biology
  18. Neutrophil-to-lymphocyte ratio an inflammatory biomarker, and prognostic marker in heart failure, cardiovascular disease and chronic inflammatory diseases: New insights for a potential predictor of anti-cytokine therapy responsiveness
    Artemio García‐Escobar, Silvio Vera, Daniel Tébar Márquez, Borja Rivero Santana, Alfonso Jurado-Román y, Santiago Jiménez‐Valero, Guillermo Galeote, José Ángel Cabrera, Raúl Moreno · 2023 · Microvascular Research
  19. Heparan sulfate proteoglycans present PCSK9 to the LDL receptor
    Camilla Gustafsen, Ditte Olsen, Joachim Vilstrup, Signe Lund, Anika Reinhardt, Niels Wellner, Torben Larsen, Christian Brix Folsted Andersen, Kathrin Weyer, Jin‐Ping Li et al. · 2017 · Nature Communications
  20. Cholesterol uptake and regulation in high-grade and lethal prostate cancers
    Konrad Hermann Stopsack, Travis A. Gerke, Ove Andrén, Swen‐Olof Andersson, Edward L. Giovannucci, Lorelei Ann Mucci, Jennifer R. Rider · 2017 · Carcinogenesis
  21. Receptor-Mediated ER Export of Lipoproteins Controls Lipid Homeostasis in Mice and Humans
    Xiao Wang, Huimin Wang, Bolin Xu, Dong Huang, Chao Nie, Longjun Pu, Gregory J. M. Zajac, Han Yan, Jingru Zhao, Fangyuan Shi et al. · 2020 · Cell Metabolism
  22. High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study
    Elena Sabini, Barbara Mazzi, Maria Antonietta Profilo, Teresa Mautone, Giamberto Casini, Roberto Rocchi, Ilaria Ionni, Francesca Menconi, Marenza Leo, Marco Nardi et al. · 2018 · Thyroid
  23. The effects of low-carbohydrate diets on cardiovascular risk factors: A meta-analysis
    Tingting Dong, Man Guo, Peiyue Zhang, Guogang Sun, Bo Chen · 2020 · PLoS ONE
  24. The Lysosome at the Intersection of Cellular Growth and Destruction
    Hijai R. Shin, Roberto Zoncu · 2020 · Developmental Cell
  25. Effects of carbohydrate-restricted diets on low-density lipoprotein cholesterol levels in overweight and obese adults: a systematic review and meta-analysis
    Gjuladin-Hellon, Teuta, Davies, Ian G, Penson, Peter, Amiri Baghbadorani, Raziyeh · 2019 · Nutrition Reviews
  26. Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity
    Deqiang Zhang, Xin Tong, Kyle VanDommelen, Neil Gupta, Kenneth Stamper, Graham F. Brady, Zhuo‐Xian Meng, Jiandie D. Lin, Liangyou Rui, M. Bishr Omary et al. · 2017 · Journal of Clinical Investigation
  27. Cardiopulmonary effects induced by occupational exposure to titanium dioxide nanoparticles
    Lin Zhao, Yifang Zhu, Zhangjian Chen, Huadong Xu, Jingwen Zhou, Shichuan Tang, Zhizhen Xu, Fanling Kong, Xinwei Li, Yifei Zhang et al. · 2018 · Nanotoxicology
  28. A gut-derived hormone regulates cholesterol metabolism
    Xiaoli Hu, Fengyi Chen, Liangjie Jia, 隆爱军, Ying Cheng Peng, Xu Li, Junfeng Huang, Xueyun Wei, Xinlei Fang, Zihua Gao et al. · 2024 · Cell
  29. Potential natural inhibitors of xanthine oxidase and HMG-CoA reductase in cholesterol regulation: in silico analysis
    Rishab Marahatha, Saroj Basnet, Bibek Raj Bhattarai, Prakriti Budhathoki, Babita Aryal, Bikash Adhikari, Ganesh Lamichhane, Darbin Kumar Poudel, Niranjan Parajuli · 2021 · BMC Complementary Medicine and Therapies
  30. Bioactive compounds from herbal medicines to manage dyslipidemia
    Xinyu Ji, Shuai Shi, Bin Liu, Mingxu Shan, Danli Tang, Wantong Zhang, Yin Zhang, Lulu Zhang, Huamin Zhang, Cheng Chang Lu et al. · 2019 · Biomedicine & Pharmacotherapy
  31. Protective role of chaperone-mediated autophagy against atherosclerosis
    Julio Madrigal‐Matute, Jenny de Bruijn, Kim van Kuijk, Dario F. Riascos‐Bernal, Antonio Díaz, Inmaculada Tasset, Adrián Martín‐Segura, Marion J. Gijbels, Bianca Sander, Susmita Kaushik et al. · 2022 · Proceedings of the National Academy of Sciences
  32. Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan
    Hiroshi Mabuchi · 2017 · Journal of Atherosclerosis and Thrombosis
  33. Potential Benefits and Risks Associated with the Use of Statins
    Nisha Khatiwada, Zhongkui Hong · 2024 · Pharmaceutics
  34. Dual signaling evoked by oxidized LDLs in vascular cells
    Anne Nègre‐Salvayre, Nathalie Augè, Caroline Camaré, Titziana Bacchetti, Gianna Ferretti, Robert Salvayre · 2017 · Free Radical Biology and Medicine
  35. The Innovative Potential of Statins in Cancer: New Targets for New Therapies
    Di Bello, Elisabetta, Zwergel, Clemens, Mai, Antonello, Valente, Sergio · 2020 · Frontiers in Chemistry
  36. The Lamin B receptor is essential for cholesterol synthesis and perturbed by disease-causing mutations
    Pei-Ling Tsai, Chenguang Zhao, ELIZABETH M. C. TURNER, Christian D. Schlieker · 2016 · eLife
  37. Can LDL cholesterol be too low? Possible risks of extremely low levels
    ANDERS G. OLSSON, Bo Angelin, Gerd Assmann, Christoph J. Binder, Ingemar Björkhem, Ángel Cedazo-Mı́nguez, Jonathan C. Cohen, Arnold von Eckardstein, Eduardo Farinaro, Dirk Müller‐Wieland et al. · 2017 · Journal of Internal Medicine
  38. Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage
    Yongjun Kou, Feng Geng, Deliang Guo · 2022 · Biomedicines
  39. Statins: a role in breast cancer therapy?
    Signe Borgquist, O. Bjarnadottir, Siker Kimbung, Thomas Patrick Ahern · 2018 · Journal of Internal Medicine
  40. Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival
    Liang Wei Wang, Zhonghao Wang, Ina Ersing, Luís Nobre, Rui Guo, Sizun Jiang, Stephen J. Trudeau, Bo Zhao, Michael P. Weekes, Benjamin E. Gewurz · 2019 · PLoS Pathogens
  41. Statins, Muscle Disease and Mitochondria
    Radha Ramachandran, Anthony S. Wierzbicki · 2017 · Journal of Clinical Medicine
  42. Interventions to promote cardiometabolic health and slow cardiovascular ageing
    Luigi Fontana · 2018 · Nature Reviews Cardiology
  43. High Cholesterol Diet Exacerbates Blood-Brain Barrier Disruption in LDLr–/– Mice: Impact on Cognitive Function
    Jade de Oliveira, Daiane Fátima Engel, Gabriela Cristina de Paula, Danúbia Bonfanti Santos, Jadna Bogado Lopes, Marcelo Farina, Eduardo Luiz Gasnhar Moreira, Andreza Fabro De Bem · 2020 · Journal of Alzheimer s Disease
  44. Functional properties of hepatocytes in vitro are correlated with cell polarity maintenance
    Anja Zeigerer, Anne Wuttke, Giovanni Marsico, Sarah Seifert, Yannis L. Kalaidzidis, Marino Zerial · 2016 · Experimental Cell Research
  45. Selective targeting of mutant adenomatous polyposis coli ( <i>APC</i> ) in colorectal cancer
    Zhang, Lu, Theodoropoulos, Panayotis C., Eskiocak, Ugur, Wang, Wentian, Moon, Young-Ah, Posner, Bruce, Williams, Noelle S., Wright, Woodring E., Kim, Sang Bum, Nijhawan, Deepak et al. · 2016 · Science Translational Medicine
  46. High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease
    Fumiaki Ito, Tomoyuki Ito · 2020 · Antioxidants
  47. ENGAGE and EMERGE: Truth and consequences?
    Lewis H. Kuller, Oscar L. López · 2021 · Alzheimer s & Dementia
  48. Atherosclerosis
    Mohammed Shamim Rahman, Kevin J. Woollard · 2017 · Advances in experimental medicine and biology
  49. Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo
    Guoshun Luo, Zhenbang Li, Xin Lin, Xinyu Li, Yu Chen, Kun Xi, Maoxu Xiao, Hanlin Wei, Lizhe Zhu, Hua Xiang · 2020 · Acta Pharmaceutica Sinica B
  50. Lipid droplets, potential biomarker and metabolic target in glioblastoma
    Deliang Guo · 2017 · Internal Medicine Review
  51. Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes
    Fabio Nascimbeni, Elisa Pellegrini, Simonetta Lugari, Alberto Mondelli, S. Bursi, Giovanna Onfiani, Francesca Carubbi, Amedeo Lonardo · 2019 · Atherosclerosis
  52. Lipids dysregulation in diseases: core concepts, targets and treatment strategies
    Tikam Chand Dakal, Feng Xiao, Chandra Kanta Bhusal, Poorna Chandrika Sabapathy, Rakesh Segal, Juan Chen, Xiaodong Bai · 2025 · Lipids in Health and Disease
  53. Transendothelial transport of lipoproteins
    Erika Jang, Jérôme Robert, Lucia Rohrer, Arnold von Eckardstein, Warren L. Lee · 2020 · Atherosclerosis
  54. Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study
    Giulia Lanzolla, Elena Sabini, Maria Antonietta Profilo, Barbara Mazzi, Angela Tindara Sframeli, Roberto Rocchi, Francesca Menconi, Mariantonietta Leo, Marco Nardi, Paolo Vitti et al. · 2018 · Journal of Endocrinological Investigation
  55. Recent Progress in in vitro Models for Atherosclerosis Studies
    Jun Chen, Xixi Zhang, Reid Millican, Tyler O. Lynd, Manas Gangasani, Shubh Malhotra, Jennifer A. Sherwood, Patrick Taejoon Hwang, Young Hye Cho, Brigitta C. Brott et al. · 2022 · Frontiers in Cardiovascular Medicine
  56. Ergosterol is mainly located in the cytoplasmic leaflet of the yeast plasma membrane
    Lukasz M. Solanko, David P. Sullivan, Yves Y. Sere, Maria Szomek, Anita Lunding, K.A. Solanko, Azra Pizovic, Lyubomir Dimitrov Stanchev, Thomas Günther Pomorski, Anant K. Menon et al. · 2017 · Traffic
  57. Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis
    Martina B. Lorey, Katariina Öörni, Petri T. Kovanen · 2022 · Frontiers in Cardiovascular Medicine
  58. Advancing targeted protein degradation for metabolic diseases therapy
    Qianqian Zhou, Haitao Xiao, Fan Yang, Yongdan Wang, Ping Li, Zu‐Guo Zheng · 2022 · Pharmacological Research
  59. Statin use and breast cancer survival – a Swedish nationwide study
    Signe Borgquist, Per Broberg, Jasaman Tojjar, Hakan Lars Olsson · 2019 · BMC Cancer
  60. The Complex Interplay between Lipids, Immune System and Interleukins in Cardio-Metabolic Diseases
    Stella Bernardi, Annalisa Marcuzzi, Elisa Piscianz, Alberto Tommasini, Bruno Fabris · 2018 · International Journal of Molecular Sciences
  61. Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians
    Enas A. Enas, Basil Varkey, Thiruvinvamalai S. Dharmarajan, Guillaume Paré, Vinay Kumar Bahl · 2019 · Indian Heart Journal
  62. Phosphate as a Pathogen of Arteriosclerosis and Aging
    Makoto Kuro‐o · 2020 · Journal of Atherosclerosis and Thrombosis
  63. Germinal Center–Derived Antibodies Promote Atherosclerosis Plaque Size and Stability
    Monica Centa, Hong Hua Jin, Lisa Hofste, Sanna Hellberg, Albert Busch, Roland Baumgartner, Nienke Juliëtte Verzaal, Sara Lind Enoksson, Ljubica Perisic Matic, Sanjay V. Boddul et al. · 2019 · Circulation
  64. Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs
    Jean‐Laurent Casanova, Mark Stuart Anderson · 2023 · Journal of Clinical Investigation
  65. ABC Transporters, Cholesterol Efflux, and Implications for Cardiovascular Diseases
    Nan Wang, Marit Westerterp · 2020 · Advances in experimental medicine and biology
  66. Adipose-Specific PPARα Knockout Mice Have Increased Lipogenesis by PASK–SREBP1 Signaling and a Polarity Shift to Inflammatory Macrophages in White Adipose Tissue
    Terry D. Hinds, Zachary A. Kipp, Mei Xu, Frederique B. Yiannikouris, Andrew J. Morris, Donald F. Stec, Walter Wahli, David E. Stec · 2021 · Cells
  67. Atherosclerosis from Newborn to Adult—Epidemiology, Pathological Aspects, and Risk Factors
    Alina-Costina Luca, Simona Georgiana David, Alexandru Gabriel David, Viorel Ţarcă, Ioana Alexandra Pădureț, Dana Elena Mîndru, Solange Tamara Roşu, Eduard Vasile Roşu, Heidrun Adu­mi­­trăchioaiei, Jana Bernic et al. · 2023 · Life
  68. SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression[S]
    L. Vergnes, Robert G. Chin, T. Q. de Aguiar Vallim, L. Fong, T. Osborne, S. Young, K. Reue · 2016 · Journal of Lipid Research
  69. A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition
    Christopher E. Mahoney, David A. Pirman, Victor Chubukov, Taryn Sleger, Sebastian Hayes, Zi Peng Fan, Eric L. Allen, Ying Chen, Lingling Huang, Meina Liu et al. · 2019 · Nature Communications
  70. Thoughts on interactions between PGRMC1 and diverse attested and potential hydrophobic ligands
    Michael A. Cahill, Amy E. Medlock · 2017 · The Journal of Steroid Biochemistry and Molecular Biology
  71. The role of sigma 1 receptor in organization of endoplasmic reticulum signaling microdomains
    Vladimir Zhemkov, Jonathon A. Ditlev, Wan-Ru Lee, Mikaela Wilson, Jen Liou, Michael K. Rosen, Безпрозванный Илья Борисович · 2021 · eLife
  72. A conserved degron containing an amphipathic helix regulates the cholesterol-mediated turnover of human squalene monooxygenase, a rate-limiting enzyme in cholesterol synthesis
    Ngee Kiat Chua, Vicky Howe, Nidhi Jatana, Lipi Thukral, Andrew John Brown · 2017 · Journal of Biological Chemistry
  73. Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases
    Hofmann, Anja, Brunssen, Coy, Morawietz, Henning · 2018 · Vascular Pharmacology
  74. LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL
    Chapman, M. John, Orsoni, Alexina, Tan, Ricardo, Mellett, Natalie A., Nguyen, Anh, Robillard, Paul, Giral, Philippe, Thérond, Patrice, Meikle, Peter J. · 2020 · Journal of Lipid Research
  75. Rationale for the use of statins in liver disease
    Robert Schierwagen, Frank Erhard Uschner, Fernando Magdaleno, Sabine Klein, Jonel Trebicka · 2017 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  76. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention
    Eun Young Lee, Yeoree Yang, Hun‐Sung Kim, Jae‐Hyoung Cho, Kun‐Ho Yoon, Wook Sung Chung, Seung‐Hwan Lee, Kiyuk Chang · 2018 · Atherosclerosis
  77. PCSK9 inhibitors and cardiovascular disease
    M. John Chapman, Jane K. Stock, Henry N. Ginsberg · 2015 · Current Opinion in Lipidology
  78. Insights into pharmacological mechanisms of polydatin in targeting risk factors-mediated atherosclerosis
    Parvej Ahmad, Sahir Sultan Alvi, Danish Iqbal, M. Salman Khan · 2020 · Life Sciences
  79. Speed Limits for Nonvesicular Intracellular Sterol Transport
    Jeremy S. Dittman, Anant K. Menon · 2016 · Trends in Biochemical Sciences
  80. Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis
    Adekunle Alabi, Xiaodan Xia, Hong-Mei Gu, Faqi Wang, Shijun Deng, Nana Yang, Ayinuer Adijiang, Donna N. Douglas, Norman M. Kneteman, Yazhuo Xue et al. · 2021 · Nature Communications
  81. Cholesterol in the Cell Membrane—An Emerging Player in Atherogenesis
    Karel Paukner, Ivana Králová Lesná, R. Poledne · 2022 · International Journal of Molecular Sciences
  82. European Heart Rhythm Association ( EHRA )/Heart Rhythm Society ( HRS )/Asia Pacific Heart Rhythm Society ( APHRS )/Latin American Heart Rhythm Society ( LAHRS ) Expert Consensus Statement on the state of genetic testing for cardiac diseases
    Arthur A.M. Wilde, Christopher Semsarian, Manlio Fabio Márquez, Alireza Sepehri Shamloo, Michael John Ackerman, Euan Angus Ashley, Eduardo Back Sternick, Héctor Barajas-Martínez, Elijah Raphael Behr, Connie R. Bezzina et al. · 2022 · Journal of Arrhythmia
  83. Metabolomic epidemiology offers insights into disease aetiology
    Harriett Fuller, Yiwen Zhu, Jayna C. Nicholas, Haley Chatelaine, Emily Drzymalla, Afrand K. Sarvestani, Sachelly Julián‐Serrano, Usman A. Tahir, Nasa Sinnott-Armstrong, Laura M. Raffield et al. · 2023 · Nature Metabolism
  84. The changing landscape of thyroid eye disease: current clinical advances and future outlook
    Malik Moledina, Erika Marie Damato, Vickie Lee · 2024 · Eye
  85. Decoding inflammation, its causes, genomic responses, and emerging countermeasures
    Jacek Hawiger, Józef Zienkiewicz · 2019 · Scandinavian Journal of Immunology
  86. Lipid and protein dynamics that shape nuclear envelope identity
    Shirin Bahmanyar, Christian D. Schlieker · 2020 · Molecular Biology of the Cell
  87. Effect of proprotein convertase subtilisin/kexin type 9 ( <scp>PCSK9</scp> ) monoclonal antibodies on new‐onset diabetes mellitus and glucose metabolism: <scp>A</scp> systematic review and meta‐analysis
    Cao, Ye‐Xuan, Liu, Hui‐Hui, Dong, Qiu‐Ting, Li, Sha, Li, Jian‐Jun · 2018 · Diabetes, Obesity and Metabolism
  88. New Insight Into Metformin-Induced Cholesterol-Lowering Effect Crosstalk Between Glucose and Cholesterol Homeostasis via ChREBP (Carbohydrate-Responsive Element-Binding Protein)-Mediated PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Regulation
    Die Hu, Yanhong Guo, Renrong Wu, Tiannan Shao, Junke Long, Bilian Yu, Huilun Helen Wang, Yonghong Luo, Haocheng Lu, Jifeng Zhang et al. · 2021 · Arteriosclerosis Thrombosis and Vascular Biology
  89. ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease
    Li, Yonghe, Macyczko, Jesse R., Liu, Chia-Chen, Bu, Guojun · 2022 · Neurobiology of Aging
  90. TDP-43 mediates SREBF2-regulated gene expression required for oligodendrocyte myelination
    Wan Yun Ho, Jer‐Cherng Chang, Kenneth Lim, Amaury Cazenave‐Gassiot, Aivi T. Nguyen, Juat Chin Foo, Sneha Muralidharan, Ashley Viera-Ortiz, Sarah J.M. Ong, Jin Hui Hor et al. · 2021 · The Journal of Cell Biology
  91. Immune Mechanisms of Plaque Instability
    Teresa Gerhardt, Arash Haghikia, Philip Stapmanns, David Manuel Leistner · 2022 · Frontiers in Cardiovascular Medicine
  92. Platelet rich fibrin and simvastatin-loaded pectin-based 3D printed-electrospun bilayer scaffold for skin tissue regeneration
    Mohamadreza Tavakoli, Mastafa H. Al‐Musawi, Alma Kalali, Afrooz Shekarchizadeh, Yeganeh Kaviani, Agrin Mansouri, Sepideh Nasiri-Harchegani, Anousheh Zargar Kharazi, Fariborz Sharifianjazi, Mamoona Sattar et al. · 2024 · International Journal of Biological Macromolecules
  93. Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry
    Konstantinos Stavroulakis, Matthias Borowski, Giovanni Battista Torsello, Theodosios Bisdas, Farzin Adili, Kai Michael Balzer, Arend Billing, Dittmar Böckler, Daniel Brixner, Sebastian Eike Debus et al. · 2017 · Journal of Vascular Surgery
  94. LXR/CD38 activation drives cholesterol-induced macrophage senescence and neurodegeneration via NAD+ depletion
    Ryo Terao, Tae Jun Lee, Jason J. Colasanti, Charles W. Pfeifer, Joseph B. Lin, Andrea C. Santeford, Keitaro Hase, Shinobu Yamaguchi, Daniel Du, Brian S. Sohn et al. · 2024 · Cell Reports
  95. Low-density lipoprotein cholesterol, lipoprotein(a) and high-sensitivity C-reactive protein are independent predictors of cardiovascular events
    Marcello Ricardo Paulista Markus, Till Ittermann, Joany Mariño, Sabine Schipf, Martin Bahls, Stephanie Könemann, Bishwas Chamling, Henry Völzke, Nágila Raquel Teixeira Damasceno, Raul Dias Santos et al. · 2025 · European Heart Journal
  96. Lipid Metabolism in Tumor-Associated Macrophages
    Yuancai Xiang, Hongming Miao · 2021 · Advances in experimental medicine and biology
  97. Ablation of Plasma Prekallikrein Decreases Low-Density Lipoprotein Cholesterol by Stabilizing Low-Density Lipoprotein Receptor and Protects Against Atherosclerosis
    Jin-Kai Wang, Yang Li, Xiao-Lu Zhao, Yuan-Bin Liu, Jing Tan, Yu-Ying Xing, Dilare Adi, Yong-Tao Wang, Zhen-Yan Fu, Yi-Tong Ma et al. · 2022 · Circulation
  98. Associations of remnant cholesterol with cardiovascular and cancer mortality in a nationwide cohort
    Yuan Tian, Yi Wu, Minjie Qi, Lijuan Song, Bowang Chen, Chunqi Wang, Jiapeng Lu, Yang Yang, Xiaoyan Zhang, Jianlan Cui et al. · 2023 · 中国科学通报:英文版
  99. The SWI/SNF chromatin-remodeling factors BAF60a, b, and c in nutrient signaling and metabolic control
    Ruo‐Ran Wang, Ran Pan, Wenjing Zhang, Junfen Fu, Jiandie D. Lin, Zhuo‐Xian Meng · 2017 · Protein & Cell
  100. Apt interpretation of comprehensive lipoprotein data in large-scale epidemiology: disclosure of fundamental structural and metabolic relationships
    Mika Ala‐Korpela, Siyu Zhao, Marjo‐Riitta Järvelin, Ville‐Petteri Mäkinen, Pauli Ohukainen · 2021 · International Journal of Epidemiology